{
    "clinical_study": {
        "@rank": "156298", 
        "acronym": "PESTOB", 
        "arm_group": [
            {
                "arm_group_label": "Unilateral Posterior Tibial Nerve Stimulation", 
                "arm_group_type": "Active Comparator", 
                "description": "Transcutaneous posterior tibial nerve stimulation applied 40 minutes every day for a duration of 4 weeks. The patient places the cathode electrode above, and the anode electrode behind, the medial malleolus, over the posterior tibial nerve and sets the stimulation intensity to a comfortable level."
            }, 
            {
                "arm_group_label": "Bilateral Posterior Tibial Nerve Stimulation", 
                "arm_group_type": "Active Comparator", 
                "description": "Transcutaneous posterior tibial nerve stimulation applied 40 minutes every day for a duration of 4 weeks. The patient places the cathode electrode above, and the anode electrode behind, the medial malleolus, over the posterior tibial nerve on both legs and sets the stimulation intensity to a comfortable level."
            }, 
            {
                "arm_group_label": "Shoulder stimulation", 
                "arm_group_type": "Active Comparator", 
                "description": "Stimulation applied 40 minutes every day for a duration of 4 weeks. The patient places the cathode and the anode electrodes on the lateral side of the left shoulder."
            }
        ], 
        "brief_summary": {
            "textblock": "This clinical trial testing three different sites of transcutaneous electrical nerve\n      stimulation for the treatment of overactive bladder (OAB)."
        }, 
        "brief_title": "Peripheral Electrical Stimulation for the Treatment of Overactive Bladder", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Idiopathic Overactive Bladder", 
        "condition_browse": {
            "mesh_term": "Urinary Bladder, Overactive"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and Females, at least 18 years of age\n\n          -  Documented symptoms of idiopathic overactive bladder for at least 3 months\n\n          -  Failure on primary OAB treatment, such as behavior modification or fluid/diet\n             management\n\n          -  Patients can remain on stable medication\n\n          -  Willing and capable of understanding and complying with all requirements of the\n             protocol\n\n          -  Signed Informed Consent to participate in the study after full discussion of the\n             research nature of the treatment and its risks and benefits\n\n        Exclusion Criteria:\n\n          -  Urinary retention or post voiding residual greater than 100 ml\n\n          -  Clinically significant bladder outlet obstruction\n\n          -  Stress predominant mixed urinary incontinence\n\n          -  Neurological disease affecting urinary bladder function, including but not limited to\n             Parkinson's disease, multiple sclerosis, stroke, spinal cord injury.\n\n          -  Pelvic surgery (such as sub-urethral sling, pelvic floor repair) within the past 6\n             months\n\n          -  Denovo OAB following pelvic surgery sub-urethral sling Intravesical or urethral\n             sphincter Botulinum Toxin Type A injections within the past 6 months\n\n          -  Percutaneous Tibial Nerve Stimulation (PTNS) therapy for overactive bladder within\n             the past 6 months\n\n          -  Any form of electric stimulation to the pelvis or lower limbs within 4 weeks\n\n          -  Vaginal prolapse greater than Stage II in the anterior compartment of the vagina\n             using International Continence Society (ICS) Pelvic Organ ProlapseQuantification\n             (POPQ) criteria.\n\n          -  Prior periurethral or transurethral bulking agent injections for bladder problems\n             within the past 12 months.\n\n          -  History of pelvic radiation therapy\n\n          -  Any skin conditions affecting treatment sites\n\n          -  Lacking dexterity to properly utilize the components of the stimulator system.\n\n          -  Presence of an implanted electro-medical device (e.g. pacemaker, defibrillator,\n             InterStim\u00ae, etc.),\n\n          -  Pregnant, nursing, suspected to be pregnant (by urine pregnancy method), or plans to\n             become pregnant during the course of the study.\n\n          -  Recurrent Urinary Tract Infections UTI (>3 UTI's in the past year)\n\n          -  History of, or current, lower tract genitourinary malignancies\n\n          -  Any clinically significant systemic disease or condition that in the opinion of the\n             Investigator would make the patient unsuitable for the study\n\n          -  Any other clinical trial within 6 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01783392", 
            "org_study_id": "STH16245"
        }, 
        "intervention": {
            "arm_group_label": [
                "Unilateral Posterior Tibial Nerve Stimulation", 
                "Bilateral Posterior Tibial Nerve Stimulation", 
                "Shoulder stimulation"
            ], 
            "intervention_name": "Transcutaneous Electrical Nerve Stimulation", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "overactive bladder", 
            "transcutaneous posterior tibial nerve stimulation", 
            "placebo PTNS"
        ], 
        "lastchanged_date": "May 14, 2013", 
        "location": {
            "contact": {
                "email": "m.slovak@sheffield.ac.uk", 
                "last_name": "Martin Slovak"
            }, 
            "facility": {
                "address": {
                    "city": "Sheffield", 
                    "country": "United Kingdom", 
                    "state": "South Yorkshire", 
                    "zip": "S10 2JF"
                }, 
                "name": "Sheffield Teaching Hospitals NHS foundation Trust, Royal Hallamshire Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "3", 
        "official_title": "Peripheral Electrical Stimulation for the Treatment of Overactive Bladder", 
        "overall_contact": {
            "email": "m.slovak@sheffield.ac.uk", 
            "last_name": "Martin Slovak"
        }, 
        "overall_official": {
            "affiliation": "Sheffield Teaching Hospitals NHS Foundation Trust", 
            "last_name": "Christopher Chapple", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The change of urinary frequency from baseline to after 4 weeks of the treatment, measured by a 3 days bladder diary.", 
                "measure": "Change in frequency of voiding", 
                "safety_issue": "No", 
                "time_frame": "baseline, 4 weeks"
            }, 
            {
                "description": "Change in the patient's bladder condition based on the PPBC questionaire from baseline to after 4 weeks of the treatment.", 
                "measure": "Change in Patient Perception of Bladder Condition (PPBC)", 
                "safety_issue": "No", 
                "time_frame": "baseline, 4 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01783392"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change in symptom severity score and HRQL score from baseline to after 4weeks of the treatment.", 
                "measure": "Changes in symptom severity score and health-related quality of life score (HRQL) based on OAB-questionnaire", 
                "safety_issue": "No", 
                "time_frame": "baseline, 4 weeks"
            }, 
            {
                "measure": "Changes in the mental/physical scores of RAND36", 
                "safety_issue": "No", 
                "time_frame": "baseline, 4 weeks"
            }, 
            {
                "description": "Change in urinary symptoms score and bother symptom score based on the ICIQ-OAB questionnaire from baseline to after 4 weeks of the treatment", 
                "measure": "Change in urinary symptoms score and bother symptom score based on the ICIQ-OAB questionnaire", 
                "safety_issue": "No", 
                "time_frame": "baseline, 4 weeks"
            }
        ], 
        "source": "Sheffield Teaching Hospitals NHS Foundation Trust", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sheffield Teaching Hospitals NHS Foundation Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}